These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18350804)

  • 1. [Eligibility of potential organ, tissue and cell donors regarding transmission of infection to recipient].
    Kalenić S; Budimir A
    Acta Med Croatica; 2007 Dec; 61(5):449-52. PubMed ID: 18350804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of serologic marker screening in identifying hepatitis B virus infection in organ, tissue, and cell donors.
    Challine D; Chevaliez S; Pawlotsky JM
    Gastroenterology; 2008 Oct; 135(4):1185-91. PubMed ID: 18694749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmission of human immunodeficiency virus and hepatitis C virus through liver transplantation.
    Ahn J; Cohen SM
    Liver Transpl; 2008 Nov; 14(11):1603-8. PubMed ID: 18975294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor screening for hepatitis B virus infection in a cell and tissue bank.
    Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ
    Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of hearts transplanted from donors with severe sepsis and infectious deaths.
    Kubak BM; Gregson AL; Pegues DA; Leibowitz MR; Carlson M; Marelli D; Patel J; Laks H; Kobashigawa JA
    J Heart Lung Transplant; 2009 Mar; 28(3):260-5. PubMed ID: 19285618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pre-transplant evaluation of the donor and recipient. Recommendations for surveillance and control of infection after transplantation].
    Cisneros JM; Cañas E; Pachón J
    Enferm Infecc Microbiol Clin; 1997 May; 15 Suppl 2():98-103. PubMed ID: 9312304
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epidemiology and prevention of donor-derived infections.
    Ison MG
    Adv Chronic Kidney Dis; 2009 Jul; 16(4):234-41. PubMed ID: 19576553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of tissue discards after implementation of anti-HBc test in a tissue bank in Spain.
    Villalba R; Fornés G; Eisman M; Gómez Villagrán JL
    Cell Tissue Bank; 2007; 8(4):303-5. PubMed ID: 17447156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplantation in the face of severe donor sepsis: pushing the boundaries?
    Pauly RP; Rayner D; Murray AG; Gilmour SM; Kunimoto DY
    Am J Kidney Dis; 2004 Oct; 44(4):e64-7. PubMed ID: 15384036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
    Katz L; Strong DM; Tegtmeier G; Stramer S
    Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Change in the serologic markers of hepatitis B after allogenic hematopoietic stem-cell transplantation].
    Woo SY; Cho SH; Lee SM; Koh MB; Noh CH; Kim CW; Choi JY; Yang JM; Han JY; Lee YS
    Korean J Hepatol; 2009 Jun; 15(2):131-9. PubMed ID: 19581765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Usage of marginal organs for liver transplantation: a way around the critical organ shortage?].
    Pratschke S; Loehe F; Graeb C; Jauch KW; Angele MK
    Zentralbl Chir; 2009 Apr; 134(2):107-12. PubMed ID: 19382040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival after orthotopic liver transplantation: the impact of antibody against hepatitis B core antigen in the donor.
    Yu L; Koepsell T; Manhart L; Ioannou G
    Liver Transpl; 2009 Oct; 15(10):1343-50. PubMed ID: 19790164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor and organ suitability: risk due to donor social behavior.
    Chiarelli AG
    Transplant Proc; 2004 Apr; 36(3):426-7. PubMed ID: 15110543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Problems in donor lung evaluation for transplantation with regard to airway infection].
    Okada Y; Matsumura Y; Hoshikawa Y; Oishi H; Noda M; Sado T; Ishida K; Hoshi F; Endo C; Miyamoto A; Hosaka T; Niikawa H; Kaizu K; Kondo T
    Kyobu Geka; 2007 Oct; 60(11):976-81. PubMed ID: 17926900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of two hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV, and p24/anti-HIV combination assays in seroconversion panels.
    Assal A; Barlet V; Deschaseaux M; Dupont I; Gallian P; Guitton C; Morel P; van Drimmelen H; David B; Lelie N; De Micco P
    Transfusion; 2009 Feb; 49(2):301-10. PubMed ID: 19389212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of deceased organ donors: no easy answers.
    Huang RC; Fishman JA
    Transplantation; 2011 Jan; 91(2):146-9. PubMed ID: 21063244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological profile of potential solid organ donors in Santa Catarina, Brazil.
    do Amaral RP; do Amaral RP; de Saidneuy AE; Ribeiro WL; de Andrade J
    Transplant Proc; 2008 Apr; 40(3):665-7. PubMed ID: 18454982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation-transmitted tuberculosis--Oklahoma and Texas, 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(13):333-6. PubMed ID: 18385639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.